Cite
HARVARD Citation
Chazan, G. et al. (2022). Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysis. Asia-Pacific journal of clinical oncology. 18 (6), pp. 642-649. [Online].